Burkina Faso Tested Malaria Vaccine Shows 77% Efficacy

April 23, 2021 11:05 AM
Embed
This program will begin at
This program has ended and is being processed for playback.

In an exclusive interview with VOA, the director of Oxford University’s Jenner Institute says their new malaria vaccine, tested in Burkina Faso, has shown a preliminary efficacy rate of 77%, which could help prevent over 400,000 deaths a year, most of them in sub-Saharan Africa.  Henry Wilkins looks at the burden of malaria on families in the region and the potential impact of the new vaccine in this report from Kaya, Burkina Faso.